mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects

To identify the most efficient methods of immunological protection against SARS-CoV-2, including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—a simultaneous side-by-side-comparison of available vaccination regimes is required. In this observational cohort study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabricius, Dorit, Ludwig, Carolin, Scholz, Judith, Rode, Immanuel, Tsamadou, Chrysanthi, Jacobsen, Eva-Maria, Winkelmann, Martina, Grempels, Aline, Lotfi, Ramin, Janda, Aleš, Körper, Sixten, Adler, Guido, Debatin, Klaus-Michael, Schrezenmeier, Hubert, Jahrsdörfer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402682/
https://www.ncbi.nlm.nih.gov/pubmed/34452043
http://dx.doi.org/10.3390/vaccines9080918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402682/
https://www.ncbi.nlm.nih.gov/pubmed/34452043
http://dx.doi.org/10.3390/vaccines9080918

Ejemplares similares